Skip to main navigation Skip to search Skip to main content

Quantifying intrinsic specificity: A potential complement to affinity in drug screening

  • Jin Wang
  • , Xiliang Zheng
  • , Yongliang Yang
  • , Dale Drueckhammer
  • , Wei Yang
  • , Gennardy Verkhivker
  • , Erkang Wang
  • CAS - Changchun Institute of Applied Chemistry
  • Stony Brook University
  • Florida State University
  • Pfizer

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

We report here the investigation of a novel description of specificity in protein-ligand binding based on energy landscape theory. We define a new term, intrinsic specificity ratio (ISR), which describes the level of discrimination in binding free energies of the native basin for a protein-ligand complex from the weaker binding states of the same ligand. We discuss the relationship between the intrinsic specificity we defined here and the conventional definition of specificity. In a docking study of molecules with the enzyme COX-2, we demonstrate a statistical correspondence between ISR value and geometrical shapes of the small molecules binding to COX-2. We further observe that the known selective (nonselective) inhibitors of COX-2 have higher (lower) ISR values. We suggest that intrinsic specificity ratio may be a useful new criterion and a complement to affinity in drug screening and in searching for potential drug lead compounds.

Original languageEnglish
Article number198101
JournalPhysical Review Letters
Volume99
Issue number19
DOIs
StatePublished - Nov 6 2007

Fingerprint

Dive into the research topics of 'Quantifying intrinsic specificity: A potential complement to affinity in drug screening'. Together they form a unique fingerprint.

Cite this